Ratings by UBS (Carter Gould)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/29/2019 | Molecular Templates | MTEM | New Coverage | Buy (N/A) |
6.67 (1.60) |
-76.01% | Details | |
| 4/10/2019 | Concert Pharmaceuticals | CNCE | Maintain | Buy (N/A) |
|
Details | ||
| 4/10/2019 | Gilead Sciences | GILD | Upgrade | Buy (Neutral) |
66.09 (65.27) |
-1.24% | Details | |
| 2/1/2019 | AC Immune SA | ACIU | Downgrade | Neutral (Buy) |
4.12 (2.29) |
-44.42% | Details | |
| 1/11/2019 | Selecta Biosciences | SELB | Maintain | Neutral (N/A) |
|
Details | ||
| 11/13/2018 | Concert Pharmaceuticals | CNCE | Maintain | Buy (N/A) |
|
Details | ||
| 11/12/2018 | BioXcel Therapeutics | BTAI | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2018 | Selecta Biosciences | SELB | Maintain | Neutral (N/A) |
|
Details |
